Genzyme history
WebApr 8, 2011 · Genzyme will become an important new platform in sanofi-aventis’ sustainable growth strategy and expand the company’s presence in biotechnology. Sanofi-aventis is making Genzyme its global center for excellence in rare diseases, headquartered in Cambridge, Massachusetts, and will be led by Christopher A. Viehbacher, sanofi-aventis’ … WebAbout Us. Through time. Sanofi, Synthélabo, Hoechst, Rhône-Poulenc Rorer led to the creation of Sanofi. These companies have accumulated over a century of experience in health, with a core concern of innovation to meet the evolution of society and the needs of patients. Today, the Sanofi Company and its 100,000 employees are dedicated to make ...
Genzyme history
Did you know?
1980s: Early history The company was started by Sheridan Snyder and George M. Whitesides in 1981. Genzyme's scientific founder was Henry Blair who had a contract with the National Institutes of Health (NIH) to produce modified enzymes for the NIH to test in clinical trials. Blair was a … See more Genzyme was an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics ) has been a fully … See more In June 2009, Genzyme's Allston, Massachusetts plant was shut down to correct a viral contamination (Vesivirus 2117). A similar … See more Genzyme has spent more than $8.2 million on lobbying from 2007 to 2009. In 2009 alone, it had 10 different organizations with a total of 49 lobbyists working on its behalf. See more In September 2015, Genzyme accepted responsibility and agreed to pay $32.59 million over U.S. charges against its marketing of the See more Genzyme focuses on six areas of medicine relating to lysosomal storage diseases, renal disease, orthopedics, transplant and … See more • Aldurazyme • Alprolix • Aubagio • Cablivi • Cerdelga • Cerezyme See more On August 30, 2010, Sanofi announced a bid to acquire Genzyme for $18.5 billion. The deal was later rejected by the board of Genzyme. On … See more WebMay 25, 2010 · Lumizyme FDA Approval History. FDA Approved: Yes (First approved May 24, 2010) Brand name: Lumizyme. Generic name: alglucosidase alfa. Company: …
WebDec 1, 2004 · Clolar FDA Approval History. FDA Approved: Yes (First approved December 28, 2004) Brand name: Clolar Generic name: clofarabine Dosage form: for Intravenous Infusion Company: Genzyme Corp. Treatment for: Acute Lymphoblastic Leukemia Clolar (clofarabine) is a purine nucleoside anti-metabolite indicated for the treatment of children … WebJul 29, 2005 · Myozyme FDA Approval History. FDA Approved: Yes (First approved April 28, 2006) Brand name: Myozyme Generic name: alglucosidase alfa Company: Genzyme Corp. Treatment for: Pompe disease Myozyme is a recombinant formulation of the human enzyme acid alpha-glucosidase (GAA) indicated for use in patients with Pompe disease …
WebFeb 3, 2024 · Eleven years after Sanofi bought Genzyme for about $20.1 billion, the parent company said Thursday it will no longer call its specialty care unit Sanofi Genzyme ― … WebApr 29, 2006 · Genzyme recently completed enrollment in its clinical trial involving patients with late-onset Pompe disease. Ninety patients have been enrolled in this international, placebo-controlled study. ... In a natural history study, 2 percent of similar infantile-onset patients were alive at 18 months of age. The pivotal trial enrolled 18 patients ...
Web2598274 (GENZ) YHD - YHD Delayed Price. Currency in USD. *Close price adjusted for splits. **Adjusted close price adjusted for splits and dividend and/or capital gain distributions.
WebNov 14, 2014 · Lemtrada FDA Approval History. FDA Approved: Yes (First approved November 14, 2014) Brand name: Lemtrada. Generic name: alemtuzumab. Dosage form: Injection. Company: Genzyme Corporation. Treatment for: Multiple Sclerosis. Lemtrada (alemtuzumab) is a CD52-directed cytolytic monoclonal antibody indicated for the … fallen ruins of the lake locationWebGranzyme. Granzymes are serine proteases released by cytoplasmic granules within cytotoxic T cells and natural killer (NK) cells. They induce programmed cell death … fallen ruins of the lake graceWebFeb 16, 2011 · June 9 - Genzyme announces settlement with Icahn and appoints two directors designated by the financier. June 28 - Viehbacher calls Termeer to set up a meeting, Termeer says he will respond soon. fallenschloss proxy 125khz